1 If CAR-T was the proof-of-concept that living drugs can wipe out blood cancers, TCR-T is the sequel that tries to take the same logic into the vastly harder terrain of solid tumors. Chimeric antigen receptors recognise intact surface proteins; engineered T-cell receptors read short peptide fragments presented on HLA molecules, letting them “see” the […]